These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Study of HLA-A, B, C, DR, DQ profile of patients with established rheumatic heart disease in Kashmir. Wani BA Indian Heart J; 1997; 49(2):152-4. PubMed ID: 9231545 [TBL] [Abstract][Full Text] [Related]
29. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364 [TBL] [Abstract][Full Text] [Related]
30. [Allogenic stem cell transplantation of adult patients from HLA-mismatch related and unrelated donors; single center experience]. Kitaori K Rinsho Ketsueki; 2002 Jun; 43(6):433-7. PubMed ID: 12134695 [No Abstract] [Full Text] [Related]
31. Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosis. Raghavan S; Selvaraj P; Swaminathan S; Alagarasu K; Narendran G; Narayanan PR Int J Immunogenet; 2009 Jun; 36(3):129-33. PubMed ID: 19392836 [TBL] [Abstract][Full Text] [Related]
32. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. Madigand M; Oger JJ; Fauchet R; Sabouraud O; Genetet B J Neurol Sci; 1982 Mar; 53(3):519-29. PubMed ID: 6978384 [TBL] [Abstract][Full Text] [Related]
33. The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens. Dankers MK; Roelen DL; Nagelkerke NJ; de Lange P; Persijn GG; Doxiadis II; Claas FH Hum Immunol; 2004 Jan; 65(1):13-9. PubMed ID: 14700591 [TBL] [Abstract][Full Text] [Related]
34. [Histocompatibility antigens in retrobulbar neuritis and multiple sclerosis]. Zavalishin IA; Nevskaia OM; Kulov BB Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):55-8. PubMed ID: 2750383 [TBL] [Abstract][Full Text] [Related]
35. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis. Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066 [TBL] [Abstract][Full Text] [Related]
36. Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections. Seppänen M; Lokki ML; Timonen T; Lappalainen M; Jarva H; Järvinen A; Sarna S; Valtonen V; Meri S Clin Infect Dis; 2001 Nov; 33(9):1604-7. PubMed ID: 11577377 [TBL] [Abstract][Full Text] [Related]
37. Cerebral cavernomas and human leukocyte antigens: preliminary clinical results. Sanus GZ; Hanimoglu H; Tanriverdi T; Yilmaz E; Ak H; Ulu MO; Kafadar AM; Canbaz B; Kaynar MY Surg Neurol; 2007 Aug; 68(2):164-6; discussion 167. PubMed ID: 17662350 [TBL] [Abstract][Full Text] [Related]
38. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions. Kageshita T; Ishihara T; Campoli M; Ferrone S Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896 [TBL] [Abstract][Full Text] [Related]
39. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Sierra B; Alegre R; Pérez AB; García G; Sturn-Ramirez K; Obasanjo O; Aguirre E; Alvarez M; Rodriguez-Roche R; Valdés L; Kanki P; Guzmán MG Hum Immunol; 2007 Jun; 68(6):531-40. PubMed ID: 17509453 [TBL] [Abstract][Full Text] [Related]